Paul DeJong Out for 2026 Season as Tigers Infield Depth Takes Major Hit

The Detroit Tigers received a significant roster setback on Thursday as veteran infielder Paul DeJong was ruled out for the remainder of the 2026 season following hamstring surgery. The injury ends what was expected to be an opportunity for the shortstop to re-establish himself at the Major League level after signing a minor league deal with Detroit.

DeJong had joined the organization as infield depth during a season in which the Tigers have already been forced to manage multiple injuries across their roster. His presence in Triple-A was viewed as a potential pathway back to the big leagues if he performed well and stayed healthy.

However, that path was abruptly cut short after his injury, which had already begun affecting him earlier in May when he was seen limping while rounding the bases in a game. Medical evaluations ultimately led to the decision for surgery.

The announcement adds another layer of frustration to what has already been a difficult stretch for both DeJong personally and the Tigers’ infield group as a whole.

1. Season-Ending Injury And Timeline

According to reports from Jon Heyman of The New York Post, DeJong will undergo surgery to address a hamstring issue that will sideline him for the rest of the season. The move effectively ends his 2026 campaign before he had the chance to advance beyond Triple-A. The injury dates back to May 12, when DeJong last appeared in a game and was visibly hampered while running the bases. That moment marked the beginning of concern over the severity of the issue. Following the injury, the Triple-A Toledo Mud Hens placed him on the full-season injured list, signaling early that a prolonged absence was likely. Further evaluations confirmed the need for surgical intervention. For Detroit, the loss removes a potential depth option who was expected to contribute if infield injuries persisted at the Major League level.

2. Continued Injury Struggles For DeJong

This latest setback continues a troubling injury trend for DeJong, who also dealt with significant health issues during the previous season. In 2025, he suffered facial fractures after being struck by a batted ball, an incident that disrupted his availability and consistency. Despite returning to action later in the year, his production remained limited across a shortened stretch of games. He finished that MLB season batting .228 with 44 hits, six home runs, and 23 RBIs in 57 appearances. Those numbers reflected both flashes of power and the challenges of regaining rhythm after a serious injury. The recurring physical setbacks have made it difficult for him to sustain momentum across consecutive seasons. His move to the Yankees on a minor league deal in January 2026 was viewed as a chance to reset his trajectory before his latest injury halted that progress.

3. Tigers’ Infield Depth Concerns

DeJong’s signing had been part of the Tigers’ broader strategy to reinforce infield depth amid ongoing injury concerns at the Major League level. The team has already dealt with multiple absences, including Gleyber Torres, Trey Sweeney, and Javier Báez, all of whom have spent time on the injured list. That cluster of injuries created an immediate need for experienced infield reinforcements, which made DeJong a logical organizational depth addition. His ability to play multiple infield positions was seen as particularly valuable given Detroit’s situation. Without him, the Tigers may need to rely more heavily on younger or less experienced options to cover innings and maintain roster flexibility throughout the season. That could place additional pressure on both the lineup and defensive alignment. For a team trying to stabilize its infield rotation, the loss of a veteran presence like DeJong further complicates roster planning moving forward.